These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2874989)

  • 21. Antianxiety activity of Gelsemium sempervirens.
    Dutt V; Dhar VJ; Sharma A
    Pharm Biol; 2010 Oct; 48(10):1091-6. PubMed ID: 20860436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines.
    Malsch U; Kieser M
    Psychopharmacology (Berl); 2001 Sep; 157(3):277-83. PubMed ID: 11605083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kava: a comprehensive review of efficacy, safety, and psychopharmacology.
    Sarris J; LaPorte E; Schweitzer I
    Aust N Z J Psychiatry; 2011 Jan; 45(1):27-35. PubMed ID: 21073405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenomic assessment of herbal drugs in affective disorders.
    Sahoo S; S B
    Biomed Pharmacother; 2019 Jan; 109():1148-1162. PubMed ID: 30551365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two-year experience with "San-Huang-Hsieh-Hsin-Tang" in essential hypertension.
    Chen HC; Hsieh MT
    Am J Chin Med; 1986; 14(1-2):51-8. PubMed ID: 3962916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Piper methysticum (kava kava).
    Altern Med Rev; 1998 Dec; 3(6):458-60. PubMed ID: 9855570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GABA
    Doron R; Sever A; Handelsman A; Toledano R; Franko M; Hirshler Y; Shamir A; Burstein O; Rehavi M
    J Mol Neurosci; 2018 May; 65(1):110-117. PubMed ID: 29737465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of anxiolytic effect of Medicago sativa in mice.
    Singh Bora K; Sharma A
    Pharm Biol; 2012 Jul; 50(7):878-82. PubMed ID: 22489538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative anxiolytic activity profile of various preparations of Passiflora incarnata linneaus: a comment on medicinal plants' standardization.
    Dhawan K; Kumar S; Sharma A
    J Altern Complement Med; 2002 Jun; 8(3):283-91. PubMed ID: 12165186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A preliminary evaluation of the anxiolytic activity of clobazam.
    Sandler K; Brunswick D; Digiacomo J; Mendels J
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):114-6. PubMed ID: 12920
    [No Abstract]   [Full Text] [Related]  

  • 31. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
    Sarris J; Teschke R; Stough C; Scholey A; Schweitzer I
    Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anxiolytic Effect of Citrus aurantium L. on Patients with Chronic Myeloid Leukemia.
    Pimenta FC; Alves MF; Pimenta MB; Melo SA; de Almeida AA; Leite JR; Pordeus LC; Diniz Mde F; de Almeida RN
    Phytother Res; 2016 Apr; 30(4):613-7. PubMed ID: 26787366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The anxiolytic-like effect of an essential oil derived from Spiranthera odoratissima A. St. Hil. leaves and its major component, β-caryophyllene, in male mice.
    Galdino PM; Nascimento MV; Florentino IF; Lino RC; Fajemiroye JO; Chaibub BA; de Paula JR; de Lima TC; Costa EA
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):276-84. PubMed ID: 22542869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical trial of suanzaorentang in the treatment of insomnia.
    Chen HC; Hsieh MT
    Clin Ther; 1985; 7(3):334-7. PubMed ID: 3888394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kava.
    Harv Womens Health Watch; 1998 Aug; 5(12):6. PubMed ID: 9713242
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical effects of anxiolytic preparation tenoten in complex therapy of essential hypertension.
    Nikol'skaya IN; Guseva IA; Bliznevskaya EV; Tret'yakova TV
    Bull Exp Biol Med; 2009 Aug; 148(2):346-8. PubMed ID: 20027367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The involvement of serotonin receptors in suanzaorentang-induced sleep alteration.
    Yi PL; Lin CP; Tsai CH; Lin JG; Chang FC
    J Biomed Sci; 2007 Nov; 14(6):829-40. PubMed ID: 17657585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The aqueous crude extract of Montanoa frutescens produces anxiolytic-like effects similarly to diazepam in Wistar rats: involvement of GABAA receptor.
    Carro-Juárez M; Rodríguez-Landa JF; Rodríguez-Peña Mde L; Rovirosa-Hernández Mde J; García-Orduña F
    J Ethnopharmacol; 2012 Sep; 143(2):592-8. PubMed ID: 22885072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical studies in patients with cardiac disorders [proceedings].
    Coste-Simonin A; Krantz D
    Br J Clin Pharmacol; 1979; 7 Suppl 1(Suppl 1):131S. PubMed ID: 35194
    [No Abstract]   [Full Text] [Related]  

  • 40. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study.
    Sarris J; Stough C; Bousman CA; Wahid ZT; Murray G; Teschke R; Savage KM; Dowell A; Ng C; Schweitzer I
    J Clin Psychopharmacol; 2013 Oct; 33(5):643-8. PubMed ID: 23635869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.